Intellia Therapeutics
NTLA
#5608
Rank
โ‚น128.26 B
Marketcap
โ‚น913.84
Share price
-0.81%
Change (1 day)
21.58%
Change (1 year)

Earnings for Intellia Therapeutics (NTLA)

Earnings in 2026 (TTM): -โ‚น36.72 Billion

According to Intellia Therapeutics's latest financial reports the company's current earnings are โ‚น59.5 Million. In 2025 the company made an earning of -โ‚น38.57 Billion, an increase over its 2024 earnings that were of -โ‚น48.5 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intellia Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น36.72 Billion-4.78%
2025 -โ‚น38.57 Billion-20.49%
2024 -โ‚น48.5 Billion7.86%
2023 -โ‚น44.97 Billion1.48%
2022 -โ‚น44.31 Billion77.01%
2021 -โ‚น25.04 Billion99.58%
2020 -โ‚น12.55 Billion34.86%
2019 -โ‚น9.31 Billion16.63%
2018 -โ‚น7.98 Billion26.35%
2017 -โ‚น6.32 Billion113.51%
2016 -โ‚น2.96 Billion135.92%
2015 -โ‚น1.26 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.59 Billion-60.96%๐Ÿ‡บ๐Ÿ‡ธ USA